Phase II trial of irinotecan plus cisplatin for pretreated patients with Ewing sarcoma and PNET
Not Applicable
- Conditions
- pretreated Ewing sarcoma or PNET
- Registration Number
- JPRN-UMIN000001529
- Lead Sponsor
- ational cancer center hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patient who have no indication for chemotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response rate
- Secondary Outcome Measures
Name Time Method